Followers | 1078 |
Posts | 80269 |
Boards Moderated | 6 |
Alias Born | 03/10/2009 |
Monday, January 13, 2020 9:28:20 PM
January 2, 2020
Bukwang Pharmaceutical announced that it has entered into an agreement with Sanofi-Aventis Korea to co-promote an ARB class antihypertensive drugs, Aprovel? (active ingredient: irbesartan) and Co-aprovel? (active ingredient: irbesartan + hydrochlorothiazide).
Starting from January 2020, Bukwang and Sanofi-Aventis Korea will co-promote to sell and market the products for hospitals and clinics nationwide. The annual sales of Aprovel? and Co-aprovel? were recorded over 20 billion KRW in 2018 based on UBIST data.
Aprovel?(ingredient: irbesartan) is an angiotensin II receptor blocker (ARB) class antihypertensive drug. Aprovel?showed clinical efficacy in both hypertension and diabetic nephropathy, so it is considered to be the most effective treatment in patients with type 2 diabetes and hypertension. In addition, the combination of the ARB with diuretic agent, Co-aprovel?(ingredient: irbesartan + hydrochlorothiazide) provides effective efficacy for patients who do not adequately controlled with monotherapy.
About 80% of Bukwang’s sales comes from original/branded products. The company has proven its ability to maintain and grow the sales of original/branded products even after generic introduction in the market. Bukwang expects overall revenue growth due to its recent activities in introducing new original products.
“Through the co-promotion of Aprovel with Sanofi-Aventis Korea, Bukwang aims to establish a solid footprint in circulatory/cardiovascular area and to achieve its goal to reach 200 billion KRW sales in 2020.”, Bukwang’s representative said.
STOP & VISIT MY BOARD AT: HOTTEST PENNY STOCK PICKS
http://investorshub.advfn.com/boards/board.aspx?board_id=19627
My posts are NOT a buy/sell recommendation, Do your Own DD, before you buy any stock - I reserve the right to buy/sell any stock
Recent ASLN News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/11/2024 12:03:28 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 09:45:26 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/24/2024 12:52:23 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/08/2024 12:02:51 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/22/2023 09:24:29 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/08/2023 09:42:19 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/27/2023 12:14:18 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/24/2023 12:32:18 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/16/2023 10:08:13 AM
- Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend] • Edgar (US Regulatory) • 08/18/2023 11:33:52 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/11/2023 11:10:26 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/20/2023 11:55:42 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/06/2023 12:11:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/06/2023 12:09:42 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/06/2023 11:59:22 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/03/2023 08:15:26 PM
Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM
Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • GCTK • Apr 17, 2024 8:00 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM
Kona Gold Beverages, Inc. Acquires Surge Distribution LLC from Loud Beverage Group, Inc. (LBEV) • KGKG • Apr 16, 2024 8:30 AM